Global Biosimilar Pipeline Analysis Market Is Estimated To Witness High Growth Owing To Increasing Investments in Biosimilar Development
Biosimilar Pipeline Analysis Market The global Biosimilar Pipeline Analysis market is estimated to be valued at US$ 20.4 Bn in 2021 and is expected to exhibit a CAGR of 15.5% over the forecast period 2022-2031, as highlighted in a new report published by Coherent Market Insights. A) Market Overview: The Biosimilar Pipeline Analysis market refers to the analysis of the pipeline of biosimilar products that are currently under development. Biosimilars are biologic medical products that are highly similar to existing approved biological products. They offer significant advantages such as reduced cost compared to originator biologics, and increasing patient access to life-saving treatments. The need for biosimilar products arises due to the high cost associated with biologic drugs and the expiry of patents for biologic products. Biosimilar development has gained traction in recent years due to favorable regulatory pathways and increasing investments by pharmaceutical companies. B) M...